{"transactions":[{"id":3028410,"issuer":{"id":8386,"kind":"organization","name":"VivoSim Labs, INC."},"owners":[{"id":146573,"kind":"person","name":"Heberlig Chris","position":1,"cik":"0001532217","reported_name":"Heberlig Chris","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CFO"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-09-17T23:19:34.000Z","date":"2020-09-15","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the option shares vest and become exercisable on September 15, 2021 and the remaining shares vest in 12 equal quarterly installments thereafter."}],"balance_after":20000,"derivative":{"exercise_price":7.64,"expiration_date":"2030-09-15","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001209191-20-051047","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1497253/000120919120051047/doc4.xml","form_type":"4"}},{"id":3409912,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":146573,"kind":"person","name":"Heberlig Chris","position":1,"cik":"0001532217","reported_name":"Heberlig Chris","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & CFO"}}],"security":"Share Option","published_at":"2019-09-19T20:16:52.000Z","date":"2019-09-17","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests and becomes exercisable as to 25% of the total grant on the first anniversary of the vesting commencement date and vests in thirty-six equal monthly installments thereafter. The vesting commencement date is September 17, 2019."}],"balance_after":50000,"derivative":{"exercise_price":8.83,"expiration_date":"2029-09-16","underlying":"Class A Common Shares","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001179110-19-010487","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000117911019010487/edgar.xml","form_type":"4"}},{"id":3608621,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":146573,"kind":"person","name":"Heberlig Chris","position":1,"cik":"0001532217","reported_name":"Heberlig Chris","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & CFO"}}],"security":"Share Option","published_at":"2019-03-06T23:30:34.000Z","date":"2019-03-04","kind":"grant","acquired":true,"shares":46000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests and becomes exercisable as to 25% of the total grant on the first anniversary of the vesting commencement date and vests in thirty-six equal monthly installments thereafter.  The vesting commencement date is March 4, 2019."}],"balance_after":46000,"derivative":{"exercise_price":17.92,"expiration_date":"2029-03-03","underlying":"Class A Common Shares","underlying_shares":46000},"source":{"system":"sec-edgar","filing":"0001104659-19-013177","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000110465919013177/a4.xml","form_type":"4"}},{"id":3809143,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":146573,"kind":"person","name":"Heberlig Chris","position":1,"cik":"0001532217","reported_name":"Heberlig Chris","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & CFO"}}],"security":"Share Option","published_at":"2018-09-24T12:58:11.000Z","date":"2018-09-20","kind":"grant","acquired":true,"shares":45000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests and becomes exercisable as to 25% of the total grant on the first anniversary of the vesting commencement date and vests in equal monthly installments over a three-year period thereafter.  The vesting commencement date is September 20, 2018."}],"balance_after":45000,"derivative":{"exercise_price":30.93,"expiration_date":"2028-09-19","underlying":"Class A Common Shares","underlying_shares":45000},"source":{"system":"sec-edgar","filing":"0001104659-18-058108","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000110465918058108/a4.xml","form_type":"4"}},{"id":3915643,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":146573,"kind":"person","name":"Heberlig Chris","position":1,"cik":"0001532217","reported_name":"Heberlig Chris","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec VP & CFO"}}],"security":"Class B Common Shares","published_at":"2018-05-29T23:18:25.000Z","date":"2018-05-29","kind":"exercise","acquired":true,"shares":74935,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each share of Class B Common Shares is convertible at any time at the election of the holder into one share of Class A Common Shares or one share of Class B1 Common Shares and will automatically convert into Class A Common Shares upon transfer to an unaffiliated party."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Each share of Class B Common Shares is convertible at any time at the election of the holder into one share of Class A Common Shares or one share of Class B1 Common Shares and will automatically convert into Class A Common Shares upon transfer to an unaffiliated party."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Each share of Class B Common Shares is convertible at any time at the election of the holder into one share of Class A Common Shares or one share of Class B1 Common Shares and will automatically convert into Class A Common Shares upon transfer to an unaffiliated party."}],"balance_after":440920,"derivative":{"underlying":"Class A Common Shares","underlying_shares":74935},"source":{"system":"sec-edgar","filing":"0001104659-18-036483","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000110465918036483/a4.xml","form_type":"4"}},{"id":3915642,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":146573,"kind":"person","name":"Heberlig Chris","position":1,"cik":"0001532217","reported_name":"Heberlig Chris","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec VP & CFO"}}],"security":"Series C Preferred Shares","published_at":"2018-05-29T23:18:25.000Z","date":"2018-05-29","kind":"exercise","acquired":false,"shares":6392,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Upon closing of the Issuer's initial public offering, the preferred shares automatically converted into the Issuer's Class A Common Shares on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Upon closing of the Issuer's initial public offering, the preferred shares automatically converted into the Issuer's Class A Common Shares on a one-for-one basis."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Upon closing of the Issuer's initial public offering, the preferred shares automatically converted into the Issuer's Class A Common Shares on a one-for-one basis."}],"balance_after":0,"derivative":{"underlying":"Class A Common Shares","underlying_shares":6392},"source":{"system":"sec-edgar","filing":"0001104659-18-036483","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000110465918036483/a4.xml","form_type":"4"}},{"id":3915641,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":146573,"kind":"person","name":"Heberlig Chris","position":1,"cik":"0001532217","reported_name":"Heberlig Chris","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec VP & CFO"}}],"security":"Series A Preferred Shares","published_at":"2018-05-29T23:18:25.000Z","date":"2018-05-29","kind":"exercise","acquired":false,"shares":74935,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Upon closing of the Issuer's initial public offering, the preferred shares automatically converted into the Issuer's Class B Common Shares on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Upon closing of the Issuer's initial public offering, the preferred shares automatically converted into the Issuer's Class B Common Shares on a one-for-one basis."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Upon closing of the Issuer's initial public offering, the preferred shares automatically converted into the Issuer's Class B Common Shares on a one-for-one basis."}],"balance_after":0,"derivative":{"underlying":"Class B Common Shares","underlying_shares":74935},"source":{"system":"sec-edgar","filing":"0001104659-18-036483","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000110465918036483/a4.xml","form_type":"4"}},{"id":3915640,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":146573,"kind":"person","name":"Heberlig Chris","position":1,"cik":"0001532217","reported_name":"Heberlig Chris","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec VP & CFO"}}],"security":"Series C Preferred Shares","published_at":"2018-05-29T23:18:25.000Z","date":"2018-02-09","kind":"purchase","acquired":true,"shares":6392,"price":15.6438,"value":99995.1696,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Upon closing of the Issuer's initial public offering, the preferred shares automatically converted into the Issuer's Class A Common Shares on a one-for-one basis."},{"field":"shares","element":"transactionShares","label":"F2","text":"Reflects the 1-for-2.73235 share consolidation effected May 11, 2018."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Reflects the 1-for-2.73235 share consolidation effected May 11, 2018."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Upon closing of the Issuer's initial public offering, the preferred shares automatically converted into the Issuer's Class A Common Shares on a one-for-one basis."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Upon closing of the Issuer's initial public offering, the preferred shares automatically converted into the Issuer's Class A Common Shares on a one-for-one basis."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F2","text":"Reflects the 1-for-2.73235 share consolidation effected May 11, 2018."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Reflects the 1-for-2.73235 share consolidation effected May 11, 2018."}],"balance_after":6392,"derivative":{"underlying":"Class A Common Shares","underlying_shares":6392},"source":{"system":"sec-edgar","filing":"0001104659-18-036483","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000110465918036483/a4.xml","form_type":"4"}},{"id":3915639,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":146573,"kind":"person","name":"Heberlig Chris","position":1,"cik":"0001532217","reported_name":"Heberlig Chris","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec VP & CFO"}}],"security":"Class A Common Shares","published_at":"2018-05-29T23:18:25.000Z","date":"2018-05-29","kind":"exercise","acquired":true,"shares":6392,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":42991,"source":{"system":"sec-edgar","filing":"0001104659-18-036483","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000110465918036483/a4.xml","form_type":"4"}}]}